Most CLL patients showed a USP7/GAPDH ratio higher than normal CD19+ lymphocytes, indicating that USP7 was generally over-represented in CLL (Figure 1C). The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.